– VEG announced a $100m financing round co-led by D1 Capital Partners and Fidelity Management & Research Company, and supported by Durable Capital Partners.
– This third round of financing will bring total equity raised to an estimated $150m since inception and positions VEG to continue to invest in its people by providing the best support system and work culture within the veterinary field.

– Checkr is a San Francisco CA-based HR technology company.
– Company raised $250m in Series E funding, valuing it at $4.6b.
– The round was led by Durable Capital, Fidelity Management & Research Company LLC and Franklin Templeton with participation from BOND Capital, Khosla Ventures, IVP, T. Rowe Price, Coatue, Accel and Y Combinator.
– The new investment will be used to expand operations and business reach.

– Databricks, a big data analytics software provider, announced that it raised $1.6 billion in a series H financing round led by Counterpoint Global, with participation from BNY Mellon and ClearBridge.
– Andreessen Horowitz, Fidelity Management & Research, and Franklin Templeton also contributed, bringing the company’s total raised to $3.5 billion at a $38 billion post-money valuation.
– Cofounder and CEO Ali Ghodsi says that the capital will be used to support Databricks’ product development, customer adoption, and the evangelization of “data lakehouse.”
– Data lakehouses — a term that came into vogue in 2020 — are data management architectures that combine data lakes, which store structured and unstructured data, with data warehouses, which perform queries and analysis.

– Laronde is a Cambridge, Mass.-based company advancing Endless RNA™ (eRNA) – a novel, engineered form of RNA that can be programmed to express therapeutic proteins inside the body.
– The company raised $440m in Series B financing.
– The round was led by Flagship Pioneering, with participation from T. Rowe Price Associates, Inc., Invus, Canada Pension Plan Investment Board (CPP Investments), Fidelity Management & Research Company, funds and accounts managed by BlackRock, and Federated Hermes Kaufmann Funds, among others.
– The new investment will be used to advance the development of the company’s eRNA platform and a broad pipeline of programs across a number of therapeutic categories.

– Rapyd received a $300m Series E funding round led by Target Global.
– The round was joined by several new investors including funds managed by Fidelity Management and Research Company, Altimeter Capital, Whale Rock Capital, BlackRock Funds, and Dragoneer, along with participation from existing investors: General Catalyst, Latitude, Durable Capital Partners, Tal Capital, Avid Ventures, and Spark Capital.
– Rapyd plans to use the funding to make several more strategic acquisitions to both support expansion in key markets and grow payment products and experiences. This will increase the scale of Rapyd’s platform not just across geographies, but also across verticals and solutions.

– T-knife Therapeutics, Inc. from Berlin, Germany develops T-cell receptor (TCR) therapeutics for solid tumor patients.
– Company completed a $110m Series B financing.
– The round was led by Fidelity Management & Research Company, LLC., with participation from other new investors including LSP, Qatar Investment Authority (QIA), Casdin Capital, Sixty Degree Capital, and CaaS Capital, along with existing investors RA Capital Management, Versant Ventures and founding investor Andera Partners.
– The new investment will be used to expand the company’s scientific team, increase manufacturing capacity and advance its pipeline of TCR-T.

– Gopuff, the go-to platform for consumers’ immediate everyday needs, announced that it has secured $1 billion in new funding at a $15 billion valuation.
– Some of the world’s foremost technology investors participated in the round, including new investors Blackstone’s Horizon platform, Guggenheim Investments, Hedosophia, MSD Partners, and Adage Capital, along with existing investors Fidelity Management and Research Company, Softbank Vision Fund 1, Atreides Management, and Eldridge.
– With these new funds, Gopuff will continue to accelerate its strategic business initiatives including further geographic expansion across North America, deeper expansion into the UK and across Europe, hiring top-tier local talent, and focusing on enhancing its technology to continue to deliver an exceptional customer experience.

– Gupshup, a San Francisco, CA-based conversational messaging company, raised $240m in follow-on funding.
– The round was led by Fidelity Management and Research Company LLC, Tiger Global, Think Investments, Malabar Investments, Harbor Spring Capital, White Oak, Neeraj Arora and others.
– The company continues to invest in product innovation for digital commerce enablement as well as expanding go-to-market initiatives in mobile-first economies around the world.

– Algolia has raised $110m in a series D round of funding led by Fidelity Management & Research Company, with participation from Twilio, Steadfast Capital Ventures, Glynn Capital, and Salesforce Ventures.
– The company is now valued at $1.1bn.
– Algolia enables customers like Slack, Stripe, Atlassian, and Ubisoft to build Google-like indexing and search capabilities into their own platforms through an API.
– This includes insights into user interactions and a suite of additional tools for A/B testing and analytics.
– Algolia also launched an API for machine learning-powered recommendations, the result of its recent acquisition of Romanian company MorphL.
– Indeed, MorphL specializes in predicting customer behavior on ecommerce sites and delivering personalized recommendations based on the context of a search.

– Deep Genomics announced the closing of a $180m Series C financing round.
– The round was led by SoftBank Vision Fund 2 and includes participation from new investors, Canadian Pension Plan Investment Board, Fidelity Management & Research Company, Alexandria Venture Investments, and existing investors Amplitude Ventures, Khosla Ventures, Magnetic Ventures, and True Ventures.
– Deep Genomics uses AI and machine learning to program and prioritize transformational RNA therapeutics for genetic diseases.
– The company has leveraged its strategic geographical advantage by combining its teams in Toronto, the birthplace of deep learning and the fastest growing technology hub in North America, with the Boston-Cambridge biotechnology hub, by hiring Jeffrey Brown, PhD, as VP of Preclinical Research, Ferdinand Massari, MD, as Chief Medical Officer, and Amanda Kay, PhD, as Chief Business Officer.

– Aristea Therapeutics, a San Diego, CA-based clinical-stage immunology focused drug development company developing novel therapies to treat serious inflammatory orphan diseases, closed a $63m Series B financing.
– The round was led by Fidelity Management & Research Company, with participation from existing investor Novo Holdings A/S and new investors Arena Pharmaceuticals and funds managed by Tekla Capital Management.
– The company intends to use the funds to continue the build-out of its leadership team, the formation of new partnerships and the advancement of the development of its portfolio of immunology focused programs to address orphan diseases.

– Wugen, Inc. completed an oversubscribed $172m Series B financing led by Abingworth and Tybourne Capital Management, and joined by new investors Fidelity Management and Research Company, Intermediate Capital Group, Sands Capital, Aisling Capital Management, Alexandria Venture Investments, Velosity Capital and Falcon Edge Capital.
– Existing investors, including RiverVest Venture Partners, LYZZ Capital, and Lightchain Capital, also participated.
– In connection with the financing, Bali Muralidhar, M.D., Ph.D., Managing Partner at Abingworth, Bosun Hau, Managing Director at Tybourne Capital Management, and Peter Kiener, Ph.D., Venture Partner at ICG, will join Wugen’s Board of Directors.

– Pine Labs from Singapore raised USD600m in funding.
– The round was led by Fidelity Management & Research Company, funds managed by BlackRock, Ishana, Tree Line, and fund advised by Neuberger Berman Investment Advisers LLC.
– The company intends to use the funds to expand operations and its business reach.

– Element Biosciences from San Diego develops DNA sequencing platform.
– The company closed a $276m Series C financing.
– Backers included new investors Janus Henderson Investors, Logos Capital, Meritech Capital Partners, Counterpoint Global (Morgan Stanley), and T. Rowe Price and existing investors Fidelity Management & Research Company, Foresite Capital, JS Capital Management LLC, RA Capital Advisors, and Venrock.
– The new investment will be used to scale commercial organization in anticipation of the launch of its next-generation sequencing solution.

– SHINE Medical Technologies LLC announced that it has closed a $150-million Series C-5 financing.
– Koch Disruptive Technologies led the round, which also included participation by Fidelity Management & Research Company, Baillie Gifford and other new and current investors.
– The financing will support SHINE’s commercialization of its diagnostic and therapeutic medical isotope technologies and position the company for future growth as it works toward developing new fusion-based technology applications.
– An existing SHINE facility produces the therapeutic medical isotope lutetitum-177 (Lu-177).
– Radiotherapeutics are one of the fastest growing areas of oncology and has significant potential for the treatment of several cancers because of their ability to directly irradiate cancer including at the late stages.

– ApplyBoard has raised C$375m in Series D funding at a post-money valuation of C$4bn.
– The round was led by Ontario Teachers’ Pension Plan Board.
– TIP focuses on late-stage venture and growth equity investments in companies developing innovative technologies.
– Existing investors Fidelity Management & Research Company LLC, BDC, Harmonic, Index Ventures, Garage Capital, and Blue Cloud Ventures also participated in the round.
– Since its founding, ApplyBoard has raised C$600m.
– ApplyBoard is on a mission to educate the world by democratizing access to international educational opportunities.

– Bright Peak Therapeutics announced a $107m Series B financing round.
– RA Capital led the round with participation from founding investor Versant Ventures and new investors Fidelity Management & Research Company, Invus, Qatar Investment Authority, funds and accounts managed by BlackRock, Alexandria Venture Investments and an undisclosed leading healthcare investment fund.
– Bright Peak uses a novel technology to chemically synthesize therapeutic cytokines by ligating together customized peptide segments.
– Bright Peak’s platform also allows for the conjugation of its enhanced cytokines as payloads to certain antibodies, creating novel and proprietary “Bright Peak Immunocytokines.”
– Bright Peak Immunocytokines will allow tissue- and cell-specific targeting of the cytokine payload with the added potential for synergistic efficacy through potency-enhancing avidity effects.

– Circle, a global financial technology firm based in Boston, raised $440m in a series E funding.
– The round was led by Fidelity Management and Research Company, Marshall Wace, Willett Advisors, Intersection Fintech Ventures, Atlas Merchant Capital, Digital Currency Group, FTX, Breyer Capital, Valor Capital Group, Pillar VC as well as Michael J. Price and Friends.
– The new investment will be used for continued growth, organizational development and market expansion opportunities.

– Bowery Farming, the largest vertical farming company in the United States, has secured $300m in additional funding.
РThe round was led by Fidelity Management & Research Company LLC, with significant follow-on investment from existing investors GV (formerly Google Ventures), General Catalyst, GGV Capital, Temasek, Groupe Art̩mis (Pinault-owned), as well as new participation from Amplo and Gaingels, a fund representing the LGBTQ community and allies.

– Vertical farming startup Bowery Farming raised $300m funding.
– The round was led by Fidelity Management & Research Company and joined by GV (formerly Google Ventures), General Catalyst, GGV Capital, Temasek and Groupe Artémis.
– Amplo and Gaingels participated, as well, along with some celebrity individual investors, including Lewis Hamilton, Chris Paul, Natalie Portman, José Andrés and Justin Timberlake.
– The funding comes as Bowery has experienced some impressive real-world growth, touting a 750% increase in availability since January of last year.

– ASAPP, Inc. announced today it raised $120m in Series C financing.
– This brings ASAPP’s total funding to $400m and doubles the company’s valuation to $1.6b from its last Series B financing.
– New investors Fidelity Management & Research Company LLC and Dragoneer joined existing investors John Doerr, March Capital, Emergence Capital, Euclidean Capital, HOF Capital, Telstra Ventures and 40 North Ventures.

– Tenstorrent is a hardware startup developing next generation computers whose Grayskull processor will go to market in the second half of 2021.
– The company raised over $200M in funding round at a $1b valuation.
– The round was led by Fidelity Management and Research Company with participation from Eclipse Ventures, Epic CG and Moore Capital.
– The new investment will be used to continue creating AI focused hardware for developers.

– Electric aviation startup Beta Technologies closed a $368m Series A funding round.
– The funding round was led by Fidelity Management & Research Company, with undisclosed additions from Amazon’s Climate Pledge Fund.
– The company’s valuation is now at $1.4 billion.

– MasterClass, a San Francisco, CA-based streaming platform for anyone to learn from the best professionals in their specific field, raised $225m in Series F funding.
– The round was led by Fidelity Management & Research Company with participation from new investors Baillie Gifford, Balyasny Asset Management and Eldridge together with existing investors IVP, Javelin, NEA and Owl Ventures, and 01 Advisors, Atomico, Bonnier, Cleo Capital, Dan Capital, NewView Capital, NextEquity Partners, Outlier Ventures, Powerhouse Capital, RPS Ventures, Family Office of Ronald Lauder and UTA.

– Wasabi, a Boston, MA-based hot cloud storage company, raised $112M in Series C funding.
– The round was led by Fidelity Management & Research Company with participation from existing investors.
– The new funding will be used to expand the company’s network of resellers, technology alliance partners, and distributors, open data centers in many new international markets, to grow its internal team across all fronts including development, sales, support, marketing, administration and operations, to make further investments in building its brand internationally and providing additional marketing support for its channel partners.

– Boundless Bio, a next-generation precision oncology company developing innovative therapeutics directed against extrachromosomal DNA (ecDNA) in aggressive cancers, announced the closing of an oversubscribed $105 Million Series B financing.
– With the proceeds of the financing, the company will advance into the clinic multiple ecDNA-directed therapeutic programs and the accompanying ecDNA Harboring Oncogenes (ECHO™) companion diagnostic and expand its pipeline of novel cancer therapies targeting ecDNA.
– RA Capital Management and Nextech Invest co-led the financing, with participation from a top-tier syndicate of funds, including Fidelity Management & Research Company LLC, Redmile Group, Wellington Management, Surveyor Capital (a Citadel company), PFM Health Sciences, and Logos Capital.

– Digital healthcare company Kry announced a funding round of over US$300m (€262m) to fuel its European expansion plans.
– The Series D funding round was led by CPP Investments (CPPIB) and Fidelity Management & Research LLC with participation from existing investors, including the Ontario Teachers’ Pension Plan (Ontario Teachers’), Index Ventures, Accel, Creandum and Project A.
Kry will use the investment to scale its platform, building on both its operations as a healthcare provider and its innovative software offerings as well as further geographic expansion. This will bring the benefits of its technology to millions more patients across Europe.

– Adagio Therapeutics, Inc., a biotechnology company developing best-in-class antibodies to broadly neutralize coronaviruses, today announced the completion of a $336m Series C financing led by RA Capital Management, with participation from new investors, including Redmile Group, Federated Hermes, Foresite Capital, ArrowMark Partners, PremjiInvest, and another leading healthcare investor.
– Existing investors Fidelity Management & Research Company, LLC, OrbiMed, Polaris Partners, Mithril, GV, Population Health Partners, Adimab and Omega Funds also participated in the financing.

– Inscripta, Inc. announced the first commercial shipment of its Onyx™ platform and the closing of a $150m Series E financing round.
– The round was led by Fidelity Management & Research Company LLC and funds and accounts advised by T. Rowe Price Associates, Inc.
– The Onyx platform is an extraordinarily powerful platform that will enable high-throughput genome editing and analysis.
– The platform will revolutionize the abilities in synthetic biology.
– Inscripta’s Onyx will be used to produce sweeteners, industrial chemicals, and medicinal components.

– ABL Space Systems has closed a Series B investment round of $170m.
– The round was led by funds and accounts advised by T. Rowe Price Associates, Inc.
– Participation in the round included existing ABL investors and new investments by Fidelity Management & Research LLC and an unnamed third global investment management firm.
– ABL is the emerging space launch company based in El Segundo, California developing the 1,000-kilogram class RS1 launch vehicle and GS0 deployable launch system.
– A first launch of RS1 is planned later in 2021, after less than four years of rapid development.
– With GS0, RS1 can be transported in shipping containers and launched from any suitable location in the world.

– Delivery startup goPuff raised $1.15bn in funding.
– The round was led by D1 Capital Partners, Fidelity Management and Research Company, Baillie Gifford, Eldridge, Reinvent Capital, Luxor Capital and SoftBank Vision Fund 1.
– The company plans to use the funding to continue expanding throughout the United States, as well as internationally, and to introduce new products.

– Squarespace, a NYC-based website building and ecommerce platform, raised approximately $300m in funding at an enterprise valuation of $10b.
– The round includes new investors Dragoneer, Tiger Global, D1 Capital Partners, Fidelity Management & Research Company, funds and accounts advised by T. Rowe Price Associates, Inc. and Spruce House with participation from existing investors Accel and General Atlantic.
– The company intends to use the funds to expand operations and its business reach.

– Stripe is a San Francisco, CA-based provider of a payments infrastructure for the internet.
– The company raised $600m in Series E funding.
– The round was led by Allianz X, Axa, Baillie Gifford, Fidelity Management & Research Company, Sequoia Capital and Ireland’s National Treasury Management Agency (NTMA).
– The new investment will be used to invest in its European operations, its Dublin headquarters in particular, and expand its Global Payments and Treasury Network.

– Graphite Bio, a next-generation gene editing company focused on therapies that harness targeted gene integration to treat or cure serious diseases, today announced the close of an oversubscribed $150 million Series B financing.
– The company will use the funds to expand and advance into the clinic its pipeline of investigational high efficiency, targeted gene integration therapies with curative potential for serious diseases.
– RA Capital Management and Rock Springs Capital led the financing with significant participation from new investors Cormorant Asset Management, Deerfield Management Company, Federated Hermes Kaufmann Funds, Fidelity Management & Research Company, Janus Henderson Investors, Logos Capital, OrbiMed, Perceptive Advisors, Surveyor Capital (a Citadel company), and Venrock Healthcare Capital Partners, joining existing investor Samsara BioCapital and founding investor Versant Ventures.

– ElevateBio is a Cambridge, Mass.-based cell and gene therapy technology company focused on advancing new cell and gene therapies.
– Company raised $525m in Series C funding.
– The round was led by Matrix Capital Management with participation from new investors SoftBank Vision Fund 2 and Fidelity Management and Research Company and existing investors MPM Capital, F2 Ventures, Redmile Group, EcoR1 Capital, Samsara BioCapital, The Invus Group, Emerson Collective, Surveyor Capital (A Citadel company), EDBI, and Vertex Ventures, iTochu, and a large insurance company.

– Monte Rosa Therapeutics announced the closing of a $95m Series C financing.
– The proceeds will be used to advance its lead development candidate into the clinic, accelerate pipeline growth and bolster its platform capabilities to rationally design and develop small molecule degraders (also known as molecular glues) that hijack the body’s innate ability to degrade proteins.
– Through this approach, Monte Rosa aims to eradicate undruggable proteins that cause or drive the progression of genomically-defined diseases intractable to standard care, including cancer.
– The financing was led by Avoro Capital Advisors with participation from additional new investors Fidelity Management & Research Company LLC, funds and accounts managed by BlackRock, funds and accounts advised by T. Rowe Price Associates, Inc., and RTW Investments, LP.

– Starling Bank, a U.K.-based challenger bank, raised £272m funding.
– The round was led by Fidelity Management & Research Company, with Qatar Investment Authority (QIA); RPMI Railpen (Railpen), the investment manager for the £31 billion Railways Pension Scheme; and global investment firm Millennium Management also participating.
– The company has now passed 2 million accounts, with 300,000 business accounts among them.
– Gross lending has passed £2 billion, with deposits at £5.4 billion.
– The company plans to use the funding to expand its lending operations in the U.K., expand into other parts of Europe and make some strategic acquisitions.

– Xsight Labs announced the closing of its Series D funding.
– The round was led by Valor Equity Partners and Atreides Management and was joined by new investor Fidelity Management & Research Company.
– Existing investors Battery Ventures, Intel Capital, M12 Microsoft’s Venture Fund and Xilinx, increased their investments.
– Additionally, Accton Technology joined as a new strategic investor.
– Xsight Labs’ Series D was significantly oversubscribed and is the largest round ever raised by our group.
– Xsight Labs emerged from stealth in December 2020 and announced the sampling availability of X1, the industry’s first 25.6T data center switch with 100G PAM4 SerDes.

– Enevate announced that it has secured a $81M Series E funding led by Fidelity Management & Research Company, providing the company with additional new resources aimed at accelerating global mass adoption of Enevate’s unique battery technology in electric vehicles.
– Existing investors, Mission Ventures and Infinite Potential Technologies, also participated in the round.
– The funding will enable Enevate to significantly expand its pre-production line designed to guide EV and other battery customers toward implementing larger-scale battery manufacturing utilizing Enevate’s silicon anode-based batteries.
– The funding would also enable Enevate to scale and grow. Included will be the hiring of additional personnel with an emphasis on scientists and engineers.
– With this latest funding round, Enevate has raised $191 million to date.

– Rad Power Bikes, North America’s largest ebike brand, today announced a minority investment of $150m from Counterpoint Global (Morgan Stanley), Fidelity Management & Research Company, The Rise Fund, the global impact investing platform managed by TPG, and funds and accounts advised by T. Rowe Price Associates, Inc.
– Existing investors Durable Capital Partners LP and Vulcan Capital also participated in the round.
– The investment reflects a historic commitment to Rad Power Bikes’ vision of a world where transportation is energy-efficient, enjoyable and accessible to all.
– Rad Power Bikes will use this new funding to extend its market leadership, drive innovation, and scale retail and service offerings.